Download PDF
Thromb Haemost 2000; 83(01): 136-140
DOI: 10.1055/s-0037-1613769
Commentary
Schattauer GmbH

Von Willebrand Disease Type 2M “Vicenza” in Italian and German Patients: Identification of the First Candidate Mutation (G3864A; R1205H) in 8 Families

Reinhard Schneppenheim
1   From the University Children’s Hospital Hamburg, Division of Paediatric Haematology and Oncology, Hamburg, Germany
,
Augusto B. Federici
2   Angelo Bianchi Bonomi Haemophilia Thrombosis Centre, Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milan, Italy
,
Ulrich Budde
3   Lab Association Keeser, Arndt and Partners, Coagulation Laboratory, Hamburg, Germany
,
Giancarlo Castaman
4   Haemophilia and Thrombosis Centre and Department of Haematology, San Bortolo Hospital, Vicenza, Italy
,
Elke Drewke
3   Lab Association Keeser, Arndt and Partners, Coagulation Laboratory, Hamburg, Germany
,
Sonja Krey
5   University Children’s Hospital Kiel
,
Pier M. Mannucci
2   Angelo Bianchi Bonomi Haemophilia Thrombosis Centre, Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milan, Italy
,
Gabi Riesen
5   University Children’s Hospital Kiel
,
Francesco Rodeghiero
4   Haemophilia and Thrombosis Centre and Department of Haematology, San Bortolo Hospital, Vicenza, Italy
,
Barbara Zieger
6   University Children’s Hospital Freiburg
,
Rainer Zimmermann
7   Rehabilitation Hospital, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Received 08 June 1999

Accepted 17 September 1999

Publication Date:
06 December 2017 (online)

    Permissions and Reprints

Summary

Von Willebrand disease type 2M “Vicenza” (VWD 2M V) is characterised by autosomal dominant inheritance, low von Willebrand factor (VWF) and the presence of “supranormal” multimers in plasma. This specific phenotype has been described in Italian and recently also in German patients. The molecular defect is linked to the VWF gene. However, no specific mutations have been identified until now. We analysed the complete coding region and adjacent intron sequences of the VWF gene in Italian families in comparison to German families with VWD 2M V by a PCR-based mutation screening, combined with SSC-and heteroduplex-analysis of exons 2 through 52, followed by direct sequencing. We identified the first heterozygous candidate mutation (G3864A; R1205H) in all affected members of the 7 Italian families and in 1 German patient but not in the unaffected family members nor on 100 chromosomes of normal subjects, suggesting a causal relationship between the mutation and the phenotype. Haplotype identity, with minor deviations in one Italian family, suggests a common but not very recent genetic origin of R1205H.

Keywords

Von Willebrand Disease Type 2M Vicenza - von Willebrand Factor Genetics
 

  • References

  • 1 Mannucci PM, Lombardi R, Castaman G, Dent JA, Lattuada A, Rodeghiero F, Zimmerman TS. Von Willebrand disease “Vicenza” with larger-thannormal (supranormal) von Willebrand factor multimers. Blood 1988; 71: 65-70.
    PubMedGoogle Scholar
  • 2 Zieger B, Budde U, Jessat U, Zimmermann R, Simon M, Katzel R, Sutor AH. New families with von Willebrand disease type 2M (Vicenza). Thromb Res 1997; 87: 57-64.
    CrossrefPubMedGoogle Scholar
  • 3 Randi AM, Sacchi E, Castaman GC, Rodeghiero F, Mannucci PM. The genetic defect of type I von Willebrand disease “Vicenza” is linked to the von Willebrand factor gene. Thromb Haemost 1993; 69: 173-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Ivy AC, Shapiro PF, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstet 1935; 60: 781.
    PubMedGoogle Scholar
  • 5 Mielke Jr CH, Kaneshiro MM, Maher JA, Weiner JM, Rapaport SJ. The standardised normal bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-15.
    PubMedGoogle Scholar
  • 6 Hardisty RM, McPherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thrombos Diathes Haemorrh 1962; 07: 215-29.
    PubMedGoogle Scholar
  • 7 Mazurier C, Parquet-Gernez A, Goudemand M. Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand’s disease. Pathol Biol Paris 1977; 25: 18-24.
    PubMedGoogle Scholar
  • 8 Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
    PubMedGoogle Scholar
  • 9 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-3.
    PubMedGoogle Scholar
  • 10 Schneppenheim R, Plendl H, Budde U. Luminography – an alternative assay for detection of von Willebrand factor multimers. Thromb Haemost 1988; 60: 133-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton BBInloes, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
    PubMedGoogle Scholar
  • 12 Mancuso DJ, Tuley EA, Westfield LA, Lester TLMancuso, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-69.
    CrossrefPubMedGoogle Scholar
  • 13 Sadler JE, Ginsburg D. A database of polymorphisms in the von Willebrand factor gene and pseudogene. For the Consortium on von Willebrand Factor Mutations and Polymorphisms and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 185-91.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A laboratory manual, Cold Spring Harbor Lab. Press; 1989
    Google Scholar
  • 15 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
    CrossrefPubMedGoogle Scholar
  • 16 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
    CrossrefPubMedGoogle Scholar
  • 17 Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus DIS80 by the PCR followed by high resolution PAGE. Am J Hum Genet 1991; 48: 137-44.
    PubMedGoogle Scholar
  • 18 Schneppenheim R, Brassard J, Krey S, Budde U, Kunicki TJ, Holmberg L, Ware J, Ruggeri ZM. Defective dimerization of von Willebrand factor subunits due to a Cys→Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci USA 1996; 93: 3581-6.
    CrossrefPubMedGoogle Scholar
  • 19 Lowe T, Sharefkin J, Yang SQ, Dieffenbach CW. A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucleic Acids Res 1990; 18: 1757-61.
    CrossrefPubMedGoogle Scholar
  • 20 Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
    CrossrefPubMedGoogle Scholar
  • 21 Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986; 46: 185-90.
    CrossrefPubMedGoogle Scholar
  • 22 Leyte A, Voorberg J, Van Schijndel HB, Duim B, Pannekoek H, Van Mourik JA. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor. Biochem J 1991; 274: 257-61.
    CrossrefPubMedGoogle Scholar
  • 23 d’Alessio PA, Castaman G, Rodeghiero F, de-Boer HC, Federici AB, Mannucci PM, de-Groot PG, Sixma JJ, Zwaginga JJ. In vivo experiments indicate that relatively high platelet deposition in von Willebrand’s disease “Vicenza” is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma. Thromb Res 1992; 65: 221-8.
    CrossrefPubMedGoogle Scholar